Dogwood

回复@xvs6: 之前把研发止痛药的公司卖给了纳斯达克上市公司dwtx，为维持dwtx的上市地位，公司主动放弃了部分权益，属于舍小利谋长远发展。//@xvs6:啥意思，哪位大神给解答一下

$Dogwood(DWTX)$
DWTX acquired global, royalty-free rights to Serpin Pharma’s SP16 in an all-stock deal representing 7.31% of fully diluted equity; a fully NCI-funded Phase 1b trial in CIPN is set to begin 1H 2026, positioning SP16 as a synergistic complement to Dogwood’...

$Dogwood(DWTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-25-094111  Act: 34  Size: 4 MB 网页链接

$Dogwood(DWTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-25-011311  Act: 34  Size: 337 KB 网页链接

$Dogwood(DWTX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-25-097990  Act: 34  Size: 1 MB 网页链接

$Dogwood(DWTX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-25-098360  Act: 34  Size: 6 MB 网页链接

$Dogwood(DWTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-25-011319  Act: 34  Size: 7 MB 网页链接

$Dogwood(DWTX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-25-098371  Act: 34  Size: 6 MB 网页链接

$Dogwood(DWTX)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 7.01, and 9.01 Accession Number: 0001104659-25-094109  Act: 34  Size: 4 MB 网页链接

$Dogwood(DWTX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-25-095632  Act: 33  Size: 457 KB 网页链接